148 related articles for article (PubMed ID: 31729307)
21. Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying β-catenin degradation.
Yuan R; Wang K; Hu J; Yan C; Li M; Yu X; Liu X; Lei J; Guo W; Wu L; Hong K; Shao J
Cancer Res; 2014 Sep; 74(18):5287-300. PubMed ID: 25056121
[TBL] [Abstract][Full Text] [Related]
22. The expression profile of the ubiquitin-like modifier FAT10 in immune cells suggests cell type-specific functions.
Schregle R; Mah MM; Mueller S; Aichem A; Basler M; Groettrup M
Immunogenetics; 2018 Jul; 70(7):429-438. PubMed ID: 29508036
[TBL] [Abstract][Full Text] [Related]
23. FAT10 promotes the invasion and migration of breast cancer cell through stabilization of ZEB2.
Zou Y; Ouyang Q; Wei W; Yang S; Zhang Y; Yang W
Biochem Biophys Res Commun; 2018 Nov; 506(3):563-570. PubMed ID: 30361097
[TBL] [Abstract][Full Text] [Related]
24. FAT10 attenuates hypoxia-induced cardiomyocyte apoptosis by stabilizing caveolin-3.
Zhou Q; Peng X; Liu X; Chen L; Xiong Q; Shen Y; Xie J; Xu Z; Huang L; Hu J; Wan R; Hong K
J Mol Cell Cardiol; 2018 Mar; 116():115-124. PubMed ID: 29438664
[TBL] [Abstract][Full Text] [Related]
25. Ubiquitin-like protein FAT10 promotes bladder cancer progression by stabilizing survivin.
Dong D; Jiang W; Lei J; Chen L; Liu X; Ge J; Che B; Xi X; Shao J
Oncotarget; 2016 Dec; 7(49):81463-81473. PubMed ID: 27806337
[TBL] [Abstract][Full Text] [Related]
26. The ubiquitin-like modifier FAT10 in antigen processing and antimicrobial defense.
Basler M; Buerger S; Groettrup M
Mol Immunol; 2015 Dec; 68(2 Pt A):129-32. PubMed ID: 25983082
[TBL] [Abstract][Full Text] [Related]
27. Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon.
Lukasiak S; Schiller C; Oehlschlaeger P; Schmidtke G; Krause P; Legler DF; Autschbach F; Schirmacher P; Breuhahn K; Groettrup M
Oncogene; 2008 Oct; 27(46):6068-74. PubMed ID: 18574467
[TBL] [Abstract][Full Text] [Related]
28. Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L.
Schmidtke G; Kalveram B; Groettrup M
FEBS Lett; 2009 Feb; 583(3):591-4. PubMed ID: 19166848
[TBL] [Abstract][Full Text] [Related]
29. The Ubiquitin-like Protein FAT10 Stabilizes eEF1A1 Expression to Promote Tumor Proliferation in a Complex Manner.
Liu X; Chen L; Ge J; Yan C; Huang Z; Hu J; Wen C; Li M; Huang D; Qiu Y; Hao H; Yuan R; Lei J; Yu X; Shao J
Cancer Res; 2016 Aug; 76(16):4897-907. PubMed ID: 27312528
[TBL] [Abstract][Full Text] [Related]
30. Regulation of Interferon Induction by the Ubiquitin-Like Modifier FAT10.
Mah MM; Roverato N; Groettrup M
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32586037
[TBL] [Abstract][Full Text] [Related]
31. The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10.
Schmidtke G; Kalveram B; Weber E; Bochtler P; Lukasiak S; Hipp MS; Groettrup M
J Biol Chem; 2006 Jul; 281(29):20045-54. PubMed ID: 16707496
[TBL] [Abstract][Full Text] [Related]
32. Structure of UBE2Z Enzyme Provides Functional Insight into Specificity in the FAT10 Protein Conjugation Machinery.
Schelpe J; Monté D; Dewitte F; Sixma TK; Rucktooa P
J Biol Chem; 2016 Jan; 291(2):630-9. PubMed ID: 26555268
[TBL] [Abstract][Full Text] [Related]
33. LMO2 blocks the UBA6-USE1 interaction and downstream FAT10ylation by targeting the ubiquitin fold domain of UBA6.
Wu C; Liu Y; Gu X; Zhu T; Yang S; Sun W
Biochem Biophys Res Commun; 2016 Sep; 478(3):1442-8. PubMed ID: 27569286
[TBL] [Abstract][Full Text] [Related]
34. The ubiquitin-like modifier FAT10 is required for normal IFN-γ production by activated CD8
Mah MM; Basler M; Groettrup M
Mol Immunol; 2019 Apr; 108():111-120. PubMed ID: 30818228
[TBL] [Abstract][Full Text] [Related]
35. FAT10 differentially stabilizes MYPT2 isoforms.
Song SE; Kim Y; Jeong H; Lee B; Lee J; Roh JS; So MW; Lee SG; Sohn DH
Biochem Biophys Res Commun; 2023 Oct; 676():115-120. PubMed ID: 37506472
[TBL] [Abstract][Full Text] [Related]
36. [Relationship between FAT10 expression and biological behaviors in infitrating ductal carcinoma of breast].
Guo H; Tan P
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 39(11):1125-30. PubMed ID: 25432368
[TBL] [Abstract][Full Text] [Related]
37. FAT10 promotes the progression of bladder cancer by upregulating HK2 through the EGFR/AKT pathway.
Zou Y; Du Y; Cheng C; Deng X; Shi Z; Lu X; Hu H; Qiu J; Jiang W
Exp Cell Res; 2021 Jan; 398(1):112401. PubMed ID: 33253711
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor mediates USE1-independent FAT10ylation under inflammatory conditions.
Schnell L; Zubrod A; Catone N; Bialas J; Aichem A
Life Sci Alliance; 2023 Nov; 6(11):. PubMed ID: 37604583
[TBL] [Abstract][Full Text] [Related]
39. Recombinant adenovirus encoding FAT10 small interfering RNA inhibits HCC growth in vitro and in vivo.
Chen J; Yang L; Chen H; Yuan T; Liu M; Chen P
Exp Mol Pathol; 2014 Apr; 96(2):207-11. PubMed ID: 24440736
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic Screen Identifies JAK2 as a Major Regulator of FAT10 Expression.
Reznik N; Kozer N; Eisenberg-Lerner A; Barr H; Merbl Y; London N
ACS Chem Biol; 2019 Dec; 14(12):2538-2545. PubMed ID: 31794190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
